APA (7th ed.) Citation

A, A., B, L., J, E., B, M., G, S., A, W., . . . F, K. (2026). Antibody responses to SARS-CoV-2 variants LP.8.1, LF.7.1, NB.1.8.1, XFG, and BA.3.2 following KP.2 monovalent mRNA vaccination. MBio, 17(1), e0290125. https://doi.org/10.1128/mbio.02901-25

Chicago Style (17th ed.) Citation

A, Abbad, et al. "Antibody Responses to SARS-CoV-2 Variants LP.8.1, LF.7.1, NB.1.8.1, XFG, and BA.3.2 Following KP.2 Monovalent MRNA Vaccination." MBio 17, no. 1 (2026): e0290125. https://doi.org/10.1128/mbio.02901-25.

MLA (9th ed.) Citation

A, Abbad, et al. "Antibody Responses to SARS-CoV-2 Variants LP.8.1, LF.7.1, NB.1.8.1, XFG, and BA.3.2 Following KP.2 Monovalent MRNA Vaccination." MBio, vol. 17, no. 1, 2026, p. e0290125, https://doi.org/10.1128/mbio.02901-25.